FC
REGN icon

FORA Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

FORA Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-564
Closed -$317K – 614
2025
Q3 		$317K Sell
564
-2,503
-82% -$1.42M 0.06% 362
2025
Q2 		$1.61M Sell
3,067
-2,380
-44% -$1.33M 0.18% 150
2025
Q1 		$3.45M Buy
5,447
+2,894
+113% +$1.99M 0.35% 89
2024
Q4 		$1.82M Buy
2,553
+1,369
+116% +$1.15M 0.21% 145
2024
Q3 		$1.24M Sell
1,184
-4,229
-78% -$4.71M 0.15% 185
2024
Q2 		$5.69M Sell
5,413
-1,911
-26% -$1.85M 0.69% 35
2024
Q1 		$7.05M Buy
+7,324
New +$6.96M 0.58% 48
2023
Q4 		– Sell
-8,244
Closed -$6.78M – 607
2023
Q3 		$6.78M Buy
+8,244
New +$6.48M 0.6% 44
2023
Q2 		– Sell
-9,504
Closed -$7.81M – 577
2023
Q1 		$7.81M Buy
+9,504
New +$7.17M 0.78% 29
2022
Q4 		– Sell
-7,204
Closed -$4.96M – 631
2022
Q3 		$4.96M Buy
+7,204
New +$4.53M 0.95% 18
2022
Q2 		– Sell
-5,250
Closed -$3.63M – 646
2022
Q1 		$3.63M Buy
+5,250
New +$3.32M 0.66% 29
2021
Q4 		– Sell
-5,006
Closed -$3.03M – 435
2021
Q3 		$3.03M Buy
5,006
+1,306
+35% +$811K 0.76% 32
2021
Q2 		$2.07M Buy
+3,700
New +$1.87M 0.38% 63
2021
Q1 		– Sell
-281
Closed -$136K – 1040
2020
Q4 		$136K Buy
+281
New +$152K 0.02% 589
2020
Q1 		– Sell
-5,278
Closed -$1.98M – 1282
2019
Q4 		$1.98M Buy
+5,278
New +$1.78M 0.2% 132

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

FORA Capital's REGN Position: Q4 2025 in Review

FORA Capital sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 564 shares — an estimated $317K sold.

FORA Capital first reported a position in REGN in Q4 2019 and held it in 15 quarters. The position peaked at $7.81M in Q1 2023. 1,385 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • FORA Capital reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • FORA Capital sold 564 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $317K.
  • FORA Capital first reported a position in Regeneron Pharmaceuticals in Q4 2019 and held it in 15 quarters.
  • FORA Capital's Regeneron Pharmaceuticals position peaked at $7.81M in Q1 2023.
  • 1,385 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.